Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Post Doctoral Researcher in Human-Centered AI for Software Engineering, Department of Electrical ...
The Section for Software Engineering and Computing Systems, at the Department of Electrical and Computer Engineering (ECE), invites applicants for a two-year postdoctoral position within the area of
-
. Description We are looking for a postdoctoral computational biologist to decipher the genomic regulatory code controlling gene expression in plants. Within the ERC-funded multiCODE project, we aim to unravel
-
innovative research, contracted policy advice, and education. We offer professional laboratories, greenhouses, semi-field, and field-scale research facilities, advanced computing capacities as
-
the end of 10th September 2025. (this is the only method that applications can be made). The start date is by mutual agreement. As part of your application, you should upload the following documents
-
diffraction and related scattering methods, Raman spectroscopy, electron microscopy (SEM and TEM). Carry out electrochemical characterization of the materials in half cells as well as in full sodium ion battery
-
and clinical translation. Supported by the Carl Zeiss Foundation , an ERC Starting Grant , and the DFG Emmy Noether Program, our lab provides a highly collaborative and interdisciplinary environment
-
researchers working with a wide range of specialisms and methods, giving you ample opportunity to exchange knowledge and experience with the various scientific fields within medicine and health. It is the
-
-funded financial support for salary or stipends (e.g., National Research Foundation Mid-Career Researcher Program, Jang Young-Shil Fellow, or similar programs), duplicate funding is not allowed. Applicants
-
for artificial intelligence in life sciences, we benefit from high-throughput computing infrastructure to support advanced data analysis and integration. Profile We are looking for a motivated postdoctoral
-
, computational drug repurposing, and de novo design of novel protein-based therapeutics. Our work also includes developing gene editing strategies to correct or inactivate mutations associated with severe